Alkermes
ALKS
#3093
Rank
A$7.33 B
Marketcap
A$44.44
Share price
0.75%
Change (1 day)
-8.10%
Change (1 year)

Alkermes (ALKS) - Total assets

Total assets on the balance sheet as of September 2025 : A$3.50 Billion

According to Alkermes's latest financial reports the company's total assets are A$3.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alkermes - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$3.30 B5.4%
2023-12-31A$3.13 B8.64%
2022-12-31A$2.88 B3.35%
2021-12-31A$2.79 B10.13%
2020-12-31A$2.53 B-1.67%
2019-12-31A$2.57 B-0.46%
2018-12-31A$2.59 B12.53%
2017-12-31A$2.30 B-3.88%
2016-12-31A$2.39 B-5.98%
2015-12-31A$2.54 B8.64%
2014-12-31A$2.34 B
2013-03-31A$1.41 B2.13%
2012-03-31A$1.38 B215.79%
2011-03-31A$0.43 B-21.82%
2010-03-31A$0.56 B-30.89%
2009-03-31A$0.81 B13.73%
2008-03-31A$0.71 B1.25%
2007-03-31A$0.70 B4.1%
2006-03-31A$0.67 B54.16%
2005-03-31A$0.43 B22.36%
2004-03-31A$0.35 B-15.45%
2003-03-31A$0.42 B-35.45%
2002-03-31A$0.65 B-18.9%
2001-03-31A$0.80 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Acorda Therapeutics
ACOR
A$0.12 B-96.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.86 B 4,059.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.28 B 8,177.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 8,860.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$172.31 B 4,813.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$60.00 B 1,610.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$229.32 B 6,438.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$161.52 B 4,505.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland